John Lee Pace
29Patents
8h-index
11Co-inventors
72Inventor score
Filing activity: Oct 3, 1995 → Oct 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5679564A | Methods for producing enhanced antigenic campylobacter bacteria and vaccines | Emerging Cross-Sectional Technologies | 29 | Expired |
| US7026288B2 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin | Human Necessities | 20 | Expired |
| US6566509B1 | Multivalent macrolide antibiotics | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5869066A | Vaccine containing a campylobacter bacterium having an enhanced antigenic property | Emerging Cross-Sectional Technologies | 16 | Expired |
| US5681736A | Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same | Emerging Cross-Sectional Technologies | 12 | Expired |
| US5897475A | Vaccines comprising enhanced antigenic helicobacter spp. | Emerging Cross-Sectional Technologies | 10 | Expired |
| US8158580B2 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin | Human Necessities | 9 | Active |
| US6858584B2 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin | Human Necessities | 8 | Expired |
| US6887843B1 | Chlamydia protein, gene sequence and uses thereof | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6642023B1 | Chlamydia protein, gene sequence and uses thereof | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6083683A | Methods for detecting shigella bacteria or antibodies to shigella bacteria with an immunoassay | Emerging Cross-Sectional Technologies | 7 | Expired |
| US6051416A | Methods for producing enhanced antigenic Helicobacter sp. | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5858352A | Vaccine containing a Shigella bacterium having an enhanced antigenic property | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7067483B2 | Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin | Human Necessities | 4 | Expired |
| US6077678A | Methods for detecting Campylobacter bacteria or antibodies to Campylobacter bacteria with an immunoassay | Emerging Cross-Sectional Technologies | 3 | Expired |
| US9872884B1 | Pristinamycin compositions, LPXC compositions, their improvements, and combinations thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US7544364B2 | Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin | Human Necessities | 2 | Expired |
| US7655246B2 | Chlamydia protein, gene sequence and uses thereof | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7534445B2 | Chlamydia protein, sequence and uses thereof | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7459524B1 | Chlamydia protein, sequence and uses thereof | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5976525A | Method for producing enhanced antigenic enteric bacteria | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7179794B2 | Multivalent macrolide antibiotics | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10898501B2 | Combination therapy effective against microorganisms, including drug resistant microorganisms | Emerging Cross-Sectional Technologies | 1 | Active |
| US7419807B2 | Chlamydia protein, gene sequence and uses thereof | Emerging Cross-Sectional Technologies | 1 | Expired |
| US9539305B1 | Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.